Delhi reports highest single-day spike in COVID-19 cases with 8,500 fresh infections

File Image

Delhi, which is currently witnessing a third wave of the coronavirus pandemic, reported more than 8,000 fresh COVID-19 infections in the past 24 hours on November 11. The National Capital logged its highest single-day spike in coronavirus cases at 8,593 new infections. This is the first time Delhi daily coronavirus tally crossed the 8,000-mark. Meanwhile, there were 7,264 coronavirus recoveries in Delhi in the past 24 hours and 85 deaths.
For live updates on coronavirus, click here

According to Health Ministry data, Delhi had recorded 7,830 fresh COVID-19 infections on November 19, which was Delhi’s highest tally until now.

With this, the state’s total coronavirus tally reached 4,59,975 including 4,10,118 recoveries or discharges and 7,228 COVID-19 deaths. According to the Delhi government, the total number of active coronavirus cases in the state now stands at 42,629.

Delhi reports 8,593 new #COVID19 cases, 7,264 recoveries/discharges/migrations and 85 deaths in the last 24 hours.

Total cases rise to 4,59,975 including 4,10,118 recoveries/discharges/migrations and 7,228 deaths.

Active cases stand at 42,629: Delhi Government pic.twitter.com/h9C30mSyoL

COVID-19 Vaccine

Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Show

Related stories

• 
  Genomics major llumina bets on India to power affordable innovation amid global headwinds
• 
  India tops as world’s most affordable digital nomad destination: Here are the top 10
• 
  OPINION | India’s Crypto Dilemma: Why half-regulation is worse than a ban

— ANI (@ANI) November 11, 2020

Follow our coverage of the coronavirus crisis here